SCHEMBL329301

SCHEMBL329301

Cc1ccccc1N1CCCC1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB1 P08588 1/20 0.67
ALDH1A1 P00352 4/20 0.59
HPGD P15428 2/20 0.59
SMN1; SMN2 Q16637 1/20 0.59
GAA P10253 2/20 0.59
SLC18A3 Q16572 1/20 0.54
KEAP1 Q14145 1/20 0.54
ALDH1A3 P47895 2/20 0.53
LMNA P02545 1/20 0.53
MCOLN3 Q8TDD5 1/20 0.53
L3MBTL1 Q9Y468 4/20 0.53
MAPT P10636 3/20 0.53
NPSR1 Q6W5P4 1/20 0.53
MAPK1 P28482 2/20 0.52
KMT2A Q03164 2/20 0.52
MEN1 O00255 1/20 0.52
THRB P10828 1/20 0.52
NR4A1 P22736 1/20 0.52
PTK2B Q14289 1/20 0.52
TSHR P16473 2/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21065768 0.98 ADRB1 (0.64) ADRB1ALDH1A1HPGDSMN1; SMN2GAA
SCHEMBL329728 0.98 ADRB1 (0.64) ADRB1ALDH1A1HPGDSMN1; SMN2GAA
Lithium SCHEMBL31448665 0.98 ADRB1 (0.64) ADRB1ALDH1A1HPGDSMN1; SMN2GAA
SCHEMBL329640 0.98 ADRB1 (0.64) ADRB1ALDH1A1HPGDSMN1; SMN2GAA
SCHEMBL31468714 0.98 ADRB1 (0.64) ADRB1ALDH1A1HPGDSMN1; SMN2GAA
SCHEMBL2332676 0.98 ADRB1 (0.64) ADRB1ALDH1A1HPGDSMN1; SMN2GAA
Bromide SCHEMBL7300370 0.98 ADRB1 (0.64) ADRB1ALDH1A1HPGDSMN1; SMN2GAA
Hydrochloric Acid SCHEMBL16446848 0.98 ADRB1 (0.64) ADRB1ALDH1A1HPGDSMN1; SMN2GAA
Hydrochloric Acid SCHEMBL6767674 0.96 ADRB1 (0.62) ADRB1ALDH1A1HPGDSMN1; SMN2GAA
Nitrogen SCHEMBL10783211 0.96 ADRB1 (0.62) ADRB1ALDH1A1HPGDSMN1; SMN2GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 180 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109678776-B Preparation method of 3-aryl succinimide compound 苏州大学 2020-07-14 CN claimed
EP-0381235-A2 Pyrrolidine compound and pharmaceutical use Eisai Co., Ltd. (JP) 1990-08-08 EP claimed
US-4578341-A Acidic photosensitive relief image-forming materials with indicator pigment or dye SENSITISERS (RESEARCH) LTD. (GB) 1986-03-25 US claimed
EP-4545515-A1 BCL-2 INHIBITORS BeiGene Switzerland GmbH (CH) 2025-04-30 EP disclosed
EP-3951890-B1 N-TYPE SEMICONDUCTOR ELEMENT, METHOD FOR PRODUCING N-TYPE SEMICONDUCTOR ELEMENT, WIRELESS COMMUNICATION DEVICE AND PRODUCT TAG TORAY INDUSTRIES (JP) 2025-01-01 EP disclosed
US-12161990-B2 EMM-41 composition, methods of making and uses thereof ExxonMobil Technology and Engineering Company (US) 2024-12-10 US disclosed
US-12029107-B2 n-type semiconductor element, method for producing n-type semiconductor element, wireless communication device, and product tag TORAY INDUSTRIES, INC. (JP) 2024-07-02 US disclosed
US-20230150946-A1 HETEROCYCLE CONTAINING STAT INHIBITORS AND COMPOSITIONS OXFORD FINANCE LLC 2023-05-18 US disclosed
EP-4015504-A1 C5AR ANTAGONISTS ChemoCentryx, Inc. (US) 2022-06-22 EP disclosed
US-20220158098-A1 n-TYPE SEMICONDUCTOR ELEMENT, METHOD FOR PRODUCING n-TYPE SEMICONDUCTOR ELEMENT, WIRELESS COMMUNICATION DEVICE, AND PRODUCT TAG TORAY INDUSTRIES, INC. (JP) 2022-05-19 US disclosed
CN-113646900-B n-type semiconductor element, method for manufacturing the same, wireless communication device, and merchandise tag 东丽株式会社 2022-05-13 CN disclosed
EP-0891765-A2 Oxidative hair dye compositions Bristol-Myers Squibb Company (US) 1999-01-20 EP disclosed
US-5851237-A Oxidative hair dye compositions and methods containing 1--(4-aminophenyl) pyrrolidines NOXELL CORPORATION 1998-12-22 US disclosed
EP-0561847-B1 PHOTOSENSITIVE POLYMERS AND PRINTING PLATES LASTRA SPA (IT) 1997-08-27 EP disclosed
EP-0561847-A1 PHOTOSENSITIVE POLYMERS AND PRINTING PLATES. LASTRA SPA (IT) 1993-09-29 EP disclosed
US-5248690-A Nervous system disorders such as Parkinson*s disease R. J. REYNOLDS TOBACCO COMPANY (US) 1993-09-28 US disclosed
WO-1992010523-A1 PHOTOSENSITIVE POLYMERS AND PRINTING PLATES LASTRA S.P.A. (IT) 1992-06-25 WO disclosed
EP-0381235-A2 Pyrrolidine compound and pharmaceutical use Eisai Co., Ltd. (JP) 1990-08-08 EP disclosed
US-4500715-A CHEMICAL INTERMEDIATES FOR PLANT SAFENING AGENTS AND DYES BAYER AKTIENGESELLSCHAFT (DE) 1985-02-19 US disclosed
US-4268438-A Cationic 1,3,4-thiadiazole dyestuffs BAYER AKTIENGESELLSCHAFT (DE) 1981-05-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230150946-A1 HETEROCYCLE CONTAINING STAT INHIBITORS AND COMPOSITIONS STAT5A, STAT5B, STAT3 ADRB1 3635/4885ALDH1A1 4293/4885HPGD 994/4885
US-12161990-B2 EMM-41 composition, methods of making and uses thereof CD14, CD68, MASP2 ADRB1 4882/4885ALDH1A1 4549/4885HPGD 3017/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.